Professional
Added to YB: 2024-02-29
Pitch date: 2024-02-28
BAYRY [neutral]
Bayer Aktiengesellschaft
+62.84%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments.
Market Cap
EUR 45.3B
Pitch Price
EUR 27.99
Price Target
N/A
Dividend
0.24%
EV/EBITDA
9.43
P/E
-228.86
EV/Sales
1.70
Sector
Pharmaceuticals
Category
turnaround
Pernas Research Passes on Bayer - $BAYRY
BAYRY: $32B market cap, $7.88 price. 20 years of stagnation due to Monsanto deal, $11B in Roundup lawsuit costs, shares -70%. $10B pharma pipeline undervalued. Crop science profits falling on price normalization. Better entry point likely ahead as litigation concerns linger.
Read full article (1 min)